Nerve News and Research

RSS

New mobile app can help people diagnosed with glaucoma

Researchers from City, University London, supported by Allergan Pharmaceuticals and Glaucoma UK, have today released the latest edition of an app to help people newly diagnosed with glaucoma.

8 Mar 2021

Scientists receive the Brain Prize for groundbreaking contributions to novel migraine therapies

The Brain Prize has been awarded to Michael A. Moskowitz, M.D., a professor of neurology at Harvard Medical School at the Massachusetts General Hospital, Charlestown, who also is supported by an NIH grant.

8 Mar 2021

Researchers create new nerve cells, spur recovery after spinal cord injury

Using genetic engineering, researchers at UT Southwestern and Indiana University have reprogrammed scar-forming cells in mouse spinal cords to create new nerve cells, spurring recovery after spinal cord injury.

8 Mar 2021

Eight hallmarks of environmental exposures that contribute to disease

A new review of existing evidence proposes eight hallmarks of environmental exposures that chart the biological pathways through which pollutants contribute to disease: oxidative stress and inflammation, genomic alterations and mutations, epigenetic alterations, mitochondrial dysfunction, endocrine disruption, altered intercellular communication, altered microbiome communities, and impaired nervous system function.

5 Mar 2021

Discovery offers a precise route to treat inflammation associated with neuropathic pain

One of the hallmarks of chronic pain is inflammation, and scientists at the UNC School of Medicine have discovered that anti-inflammatory cells called MRC1+ macrophages are dysfunctional in an animal model of neuropathic pain.

5 Mar 2021

Study reveals potential risk factors for developing nerve damage after cancer treatment

A low hemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.

4 Mar 2021

The Role of D-Amino Acids in Humans

In this interview, Dr. Daniel Armstrong from the University of Texas at Arlington talks to News-Medical Life Sciences about his upcoming Pittcon presentation.

From Pittcon 4 Mar 2021

UTHSC researchers awarded $1.9 million to study white matter mechanisms underlying dementia

The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia.

3 Mar 2021

Researchers identify drug target to fight Parkinson’s and Alzheimer’s disease

Neurodegenerative disorders such as Parkinson's and Alzheimer's disease are in the firing line after researchers identified an attractive therapeutic drug target.

3 Mar 2021

Newly developed maps show how human brains are kept nourished

Our brains are non-stop consumers. A labyrinth of blood vessels, stacked end-to-end comparable in length to the distance from San Diego to Berkeley, ensures a continuous flow of oxygen and sugar to keep our brains functioning at peak levels.

3 Mar 2021

Yale researchers identify multiple genes involved in suppression of axon regeneration

When central nervous system cells in the brain and spine are damaged by disease or injury, they fail to regenerate, limiting the body's ability to recover.

2 Mar 2021

A region within GLI1 gene could potentially be targeted as cancer treatment

Scientists from the Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago found that a region within the DNA of the cancer-promoting GLI1 gene is directly responsible for regulating this gene's expression.

1 Mar 2021

NYU Oral Cancer Center receives $3.1 million grant to explore the interplay between nerves and cancer

NYU Oral Cancer Center has been awarded a five-year, $3.1 million grant (R01 CA231396) by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

1 Mar 2021

Study demonstrates intricate relationship between Prpf19 and Exoc7 in inherited ataxias

Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph Disease (MJD), describes the most common form of dominantly inherited ataxia in many populations worldwide, including Hong Kong and mainland China.

1 Mar 2021

University of Toronto, Fujitsu develop new technology to streamline radiation treatment plans

Fujitsu Laboratories, Ltd. in collaboration with researchers at the University of Toronto (U of T) today announced the development of a technology for dramatically streamlining the creation of radiation treatment plans for Gamma Knife radiosurgery, leveraging Fujitsu's quantum-inspired computing technology, the Digital Annealer, which rapidly solves combinatorial optimization problems.

27 Feb 2021

Researchers develop an electroceutical for preterm labor detection and treatment

Preterm labor comprises 12.7% of all pregnancies. Although the overall rate of pregnancy is decreasing, the occurrence of premature birth due to preterm labor in south korea has been increasing over the past 7 years.

26 Feb 2021

Well-known spasmolytic drug can suppress inflammatory response in astrocytes

Biologists from RUDN University confirmed that a well-known spasmolytic drug called hymecromone can suppress the inflammatory response in astrocytes, important glial cells of the central nervous system.

26 Feb 2021

FDA permits marketing of new device to protect athletes from harmful effects of head impacts

Today, the U.S. Food and Drug Administration authorized marketing of a new device intended to be worn around the neck of athletes aged 13 years and older during sports activities to aid in the protection of the brain from the effects associated with repetitive sub-concussive head impacts.

26 Feb 2021

Study indicates neural pathway that provides pain relief, reduces cravings for opioids

Researchers have discovered that there may be a new pathway in the brain that provides pain relief and reduces cravings for opioids.

26 Feb 2021

New method helps study the effects of receptor clustering in living cells

Our body consists of 100 trillion cells that communicate with each other, receive signals from the outside world and react to them.

26 Feb 2021

Nerve News and Research

New mobile app can help people diagnosed with glaucoma

Scientists receive the Brain Prize for groundbreaking contributions to novel migraine therapies

Researchers create new nerve cells, spur recovery after spinal cord injury

Eight hallmarks of environmental exposures that contribute to disease

Discovery offers a precise route to treat inflammation associated with neuropathic pain

Study reveals potential risk factors for developing nerve damage after cancer treatment

The Role of D-Amino Acids in Humans

UTHSC researchers awarded $1.9 million to study white matter mechanisms underlying dementia

Researchers identify drug target to fight Parkinson’s and Alzheimer’s disease

Newly developed maps show how human brains are kept nourished

Yale researchers identify multiple genes involved in suppression of axon regeneration

A region within GLI1 gene could potentially be targeted as cancer treatment

NYU Oral Cancer Center receives $3.1 million grant to explore the interplay between nerves and cancer

Study demonstrates intricate relationship between Prpf19 and Exoc7 in inherited ataxias

University of Toronto, Fujitsu develop new technology to streamline radiation treatment plans

Researchers develop an electroceutical for preterm labor detection and treatment

Well-known spasmolytic drug can suppress inflammatory response in astrocytes

FDA permits marketing of new device to protect athletes from harmful effects of head impacts

Study indicates neural pathway that provides pain relief, reduces cravings for opioids

New method helps study the effects of receptor clustering in living cells

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News